Toxoplasma Uveitis in a Patient with Ankylosing Spondylitis
Author(s) -
Hülya Devecı,
Şenol Kobak
Publication year - 2013
Publication title -
turkish journal of parasitology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.207
H-Index - 18
eISSN - 2146-3077
pISSN - 1300-6320
DOI - 10.5152/tpd.2013.48
Subject(s) - ankylosing spondylitis , medicine , uveitis , vitrectomy , trimethoprim , surgery , clindamycin , medical treatment , spondylitis , sulfamethoxazole , intermediate uveitis , visual acuity , dermatology , ophthalmology , antibiotics , intensive care medicine , anterior uveitis , biology , microbiology and biotechnology
In this paper, a posterior uveitis case was reported in a patient who was being followed and under treatment for Ankylosing Spondylitis. Toxoplasma antibodies were investigated and anti-toxoplasma IgG was positive. Systematic treatment (Sulfamethoxazole/Trimethoprim and Clindamycin) was started. Despite medical treatment, reduction in visual acuity and development of dense membranous condensation in vitreous occurred. Surgical vitrectomy was performed. When posterior uveitis develops in patients who undergo immunosuppressive treatment, toxoplasma is among the first infectious agents that we should consider. A delay in diagnosis and treatment may result in failure in obtaining the desired outcome from medical treatment and a shift to surgical treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom